The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review
Authors
Keywords
-
Journal
Advances in Nutrition
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-12-22
DOI
10.1093/advances/nmaa180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial
- (2020) Donna L. Herber et al. Trials
- A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer’s Disease
- (2020) Samuel T. Henderson et al. JOURNAL OF ALZHEIMERS DISEASE
- Influence of Vitamin D Deficiency on the Development of Opportunistic Infection in People Living with HIV/AIDS (PWHAs)
- (2020) Shinwon Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease
- (2019) Jason Brandt et al. JOURNAL OF ALZHEIMERS DISEASE
- A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment
- (2019) Mélanie Fortier et al. Alzheimers & Dementia
- Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases
- (2019) Alessandro Leone et al. Nutrients
- The impact of keto-adaptation on exercise performance and the role of metabolic-regulating cytokines
- (2019) Matthew Sherrier et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- How do impairments in cognitive functions affect activities of daily living functions in older adults?
- (2019) Meng-Ta Lee et al. PLoS One
- Pilot study of a ketogenic diet in relapsing-remitting MS
- (2019) J. Nicholas Brenton et al. Neurology-Neuroimmunology & Neuroinflammation
- Modified Ketogenic Diet Is Associated With Improved Cerebrospinal Fluid Biomarker Profile, Cerebral Perfusion, And Cerebral Ketone Body Uptake In Older Adults At-Risk For Alzheimer’s Disease: A Pilot Study
- (2019) Bryan J. Neth et al. NEUROBIOLOGY OF AGING
- Differential Metabolism of Medium-Chain Fatty Acids in Differentiated Human-Induced Pluripotent Stem Cell-Derived Astrocytes
- (2019) Sarah Sonnay et al. Frontiers in Physiology
- Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment
- (2019) Ravinder Nagpal et al. EBioMedicine
- Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4−/−: A double-blind, randomized, placebo-controlled crossover trial
- (2019) Qing Xu et al. CLINICAL NUTRITION
- Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks
- (2019) Aneela Rahman et al. Frontiers in Aging Neuroscience
- Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives
- (2019) Angela M. Poff et al. Frontiers in Neuroscience
- Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study
- (2018) Nare Torosyan et al. EXPERIMENTAL GERONTOLOGY
- The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review
- (2018) Jacqueline K. Kueper et al. JOURNAL OF ALZHEIMERS DISEASE
- Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
- (2018) A.I. Duarte et al. NEUROPHARMACOLOGY
- The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review
- (2018) Cliff J. d C. Harvey et al. PeerJ
- Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial
- (2018) Matthew C.L. Phillips et al. MOVEMENT DISORDERS
- Effectiveness of interventions aimed at improving dietary behaviours among people at higher risk of or with chronic non-communicable diseases: an overview of systematic reviews
- (2018) Sarah Browne et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study
- (2018) Lisa Mosconi et al. PLoS One
- The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
- (2018) Janusz W. Błaszczyk Frontiers in Aging Neuroscience
- Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis
- (2018) Markus Bock et al. EBioMedicine
- The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction
- (2017) Yuri Zilberter et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
- (2017) Alexander Swidsinski et al. Frontiers in Microbiology
- On the Metabolism of Exogenous Ketones in Humans
- (2017) Brianna J. Stubbs et al. Frontiers in Physiology
- Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague–Dawley rats
- (2016) Shannon L. Kesl et al. Nutrition & Metabolism
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms
- (2016) In Young Choi et al. Cell Reports
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy
- (2015) Magnhild Kverneland et al. EPILEPSY & BEHAVIOR
- Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
- (2015) Jan Lewerenz et al. Frontiers in Neuroscience
- Dietary treatment in adults with refractory epilepsy: A review
- (2014) P. Klein et al. NEUROLOGY
- Fatty Acid Metabolism in Carriers of Apolipoprotein E Epsilon 4 Allele: Is It Contributing to Higher Risk of Cognitive Decline and Coronary Heart Disease?
- (2014) Raphaël Chouinard-Watkins et al. Nutrients
- Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
- (2014) Antonio Paoli et al. Biomed Research International
- Modified Atkins diet vs classic ketogenic formula in intractable epilepsy
- (2013) O. F. El-Rashidy et al. ACTA NEUROLOGICA SCANDINAVICA
- Effects of Low-Carbohydrate Diets Versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials
- (2012) Tian Hu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Alternative diets to the classical ketogenic diet—Can we be more liberal?
- (2012) Maria J. Miranda et al. EPILEPSY RESEARCH
- BAD-Dependent Regulation of Fuel Metabolism and KATP Channel Activity Confers Resistance to Epileptic Seizures
- (2012) Alfredo Giménez-Cassina et al. NEURON
- Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes
- (2012) Talib A. Hussain et al. NUTRITION
- Long-term dietary intervention trials: critical issues and challenges
- (2012) Georgina E Crichton et al. Trials
- Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study
- (2011) Samuel T Henderson et al. BMC Medical Genetics
- Diagnostic Accuracy of Point-of-Care Testing for Diabetic Ketoacidosis at Emergency-Department Triage: -Hydroxybutyrate versus the urine dipstick
- (2011) S. Arora et al. DIABETES CARE
- What is the clinically relevant change on the ADAS-Cog?
- (2011) Anette Schrag et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
- (2011) Claire Hinnell et al. MOVEMENT DISORDERS
- Recruiting older people to a randomised controlled dietary intervention trial - how hard can it be?
- (2010) Sarah E Forster et al. BMC Medical Research Methodology
- Dietary ketosis enhances memory in mild cognitive impairment
- (2010) Robert Krikorian et al. NEUROBIOLOGY OF AGING
- Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet
- (2010) Julie B. Milder et al. NEUROBIOLOGY OF DISEASE
- Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE 4 but not by the common PPAR-α L162V polymorphism in men
- (2009) Mélanie Plourde et al. BRITISH JOURNAL OF NUTRITION
- Short-Term Effects of Prolonged Fasting on Multiple Sclerosis
- (2009) Mohammad Saadatnia et al. EUROPEAN NEUROLOGY
- The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease
- (2009) Kenneth Rockwood et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
- (2009) Samuel T Henderson et al. Nutrition & Metabolism
- Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis
- (2009) A. N. Fabricatore et al. Obesity Reviews
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's disease☆
- (2008) Roberta Diaz Brinton ADVANCED DRUG DELIVERY REVIEWS
- The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial
- (2008) Elizabeth G Neal et al. LANCET NEUROLOGY
- Levodopa unresponsive symptoms in Parkinson disease
- (2008) Kapil Sethi MOVEMENT DISORDERS
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- What is “quality of evidence” and why is it important to clinicians?
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now